IL-11 Regulates Macrophage Effector Function Through the Inhibition of Nuclear Factor-κB

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5661-5670

  Trepicchio, William L ^a   Wang, Lili ^a   Bozza, Mary ^a   Dorner, Andrew J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA BINDING PROTEIN; I KAPPA B; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 11; MESSENGER RNA; RECOMBINANT INTERLEUKIN 11; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; C57BL MOUSE; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; MACROPHAGE ACTIVATION; METABOLISM; MOUSE; PERITONEUM MACROPHAGE; PHYSIOLOGY;

ANIMALS; CYTOKINES; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION; INTERLEUKIN-11; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; NF-KAPPA B; RECOMBINANT PROTEINS; RNA, MESSENGER;

EID: 0031298532     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Schook, L., and D. Laskin. 1994. Xenobiotics and Inflammation. Academic Press, San Diego, p. 361.
2. Laskin, D. L., and K. J. Pendino. 1995. Macrophages and inflammatory mediators in tissue injury. Annu. Rev. Pharmacol. Toxicol. 35:655.
3. Feldmann, M., F. M. Brennan, M. Elliott, P. Katsikis, and R. N. Maini. 1994. TNF alpha as a therapeutic target in rheumatoid arthritis. Circ. Shock 43:179.
4. Arend, W. P., and J. M. Dayer. 1990. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum. 33:305.
5. Ligumsky, M., P. L. Simon, F. Karmeli, and D. Rachmilewitz. 1990. Role of IL-1 in inflammatory bowel disease: enhanced production during active disease. Gut 31:686.
6. Murch, S. H., V. A. Lamkin, M. O. Savage, J. A. Walker-Smith, and T. T. MacDonald. 1991. Serum levels of tumor necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut 32:913.
7. + T cells. Immunity 1:553.
8. Sartor, R. B. 1994. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 106:533.
9. Alexander, H. R., G. M. Doherty, C. M. Buresh, D. J. Venzon, and J. A. Norton. 1991. A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J. Exp. Med. 173:1029.
10. Sibille, Y., and H. Y. Reynolds. 1990. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 141:471.
11. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147: 3815.
12. Wahl, S. M., N. McCartney-Francis, J. B. Allen, E. B. Dougherty, and S. F. Dougherty. 1990. Macrophage production of TGF-beta and regulation by TGF-beta. Ann. NY Acad. Sci. 593:188.
13. Trepicchio, W., M. Bozza, G. Pedneault, and A. Dorner. 1996. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J. Immunol. 157: 3627.
14. Redlich, C. A., Z. Gao, S. Rockwell, M. Kelley, and J. A. Elias. 1996. IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J. Immunol. 157:1705.
15. Keith, J. C. Jr., L. Albert, S. T. Sonis, C. J. Pfeiffer, and R. G. Schaub. 1994. IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology. Stem Cells (Dayt) 12(Suppl. 1):79.
16. Wang, P., P. Wu, M. I. Siegel, R. W. Egan, and M. M. Billah. 1995. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 270:9558.
17. Romano, M. F., A. Lamberti, A. Petrella, R. Bisogni, P. F. Tassone, S. Formisano, S. Venuta, and M. C. Turco. 1996. IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes. J. Immunol. 156:2119.
18. Arsura, M., M. Wu, and G. E. Sonenshein. 1996. TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha. Immunity 5:31.
19. Thanos, D., and T. Maniatis. 1995. NF-kappa B: a lesson in family values. Cell 80:529.
20. Baeuerle, P. A., and D. Baltimore. 1996. NF-kappa B: ten years after. Cell 87:13.
21. Barnes, P. J., and M. Karin. 1997. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066.
22. Paul, S. R., B. A. Barut, F. Bennett, M. A. Cochran, and K. C. Anderson. 1992. Lack of a role of interleukin 11 in the growth of multiple myeloma. Leuk. Res. 16:247.
23. Goldman, S. J. 1995. Preclinical biology of interleukin 11: a multifunctional hematopoietic cytokine with potent thrombopoietic activity. Stem Cells (Dayt) 13:462.
24. Tsang, M. 1990. Lymphokine: cell biology, physiology, and therapy. Lymphokine Res. 9:607.
25. Trepicchio, W. L., M. A. Dyer, and M. H. Baron. 1993. Developmental regulation of the human embryonic beta-like globin gene is mediated by synergistic interactions among multiple tissue- and stage-specific elements. Mol. Cell. Biol. 13:7457.
26. Zinn, K., D. DiMaio, and T. Maniatis. 1983. Identification of two distinct regulatory regions adjacent to the human β-interferon gene. Cell 34:865.
27. Dorner, A. J., and R. J. Kaufman. 1990. Analysis of synthesis, processing and secretion of proteins expressed in mammalian cells. In Methods in Enzymology, Vol. 185. D. Goeddall, ed. Academic Press, San Diego, p. 577.
28. Elias, J. A., T. Zheng, O. Einarsson, M. Landry, T. Trow, N. Rebert, and J. Panuska. 1994. Epithelial interleukin-11: regulation by cytokines, respiratory syncytial virus, and retinoic acid. J. Biol. Chem. 269:22261.
29. Yang, L., and Y. C. Yang. 1994. Regulation of interleukin (IL)-11 gene expression in IL-1 induced primate bone marrow stromal cells. J. Biol. Chem. 269:32732.
30. Suen, Y., M. Chang, S. M. Lee, J. S. Buzby, and M. S. Cairo. 1994. Regulation of interleukin-11 protein and mRNA expression in neonatal and adult fibroblasts and endothelial cells. Blood 84:4125.
31. Kopp, E. B., and S. Ghosh. 1995. NF-kappa B and rel proteins in innate immunity. Adv. Immunol. 58:1.
32. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12:141.
33. Scheinman, R. I., P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin, Jr. 1995. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270:283.
34. Auphan, N., J. A. Di Donato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286.
35. Liou, H. C., and D. Baltimore. 1993. Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system. Curr. Opin. Cell Biol. 5:477.
36. Jonat, C., H. J. Rahmsdorf, K.-K. Park, A. C. B. Cato, S. Gebel, H. Ponta, and P. Herrlich. 1990. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189.
37. Dokter, W. H., L. Tuyt, S. J. Sierdsema, M. T. Esselink, and E. Vellenga. 1995. The spontaneous expression of interleukin-1 beta and interleukin-6 is associated with spontaneous expression of AP-1 and NF-kappa B transcription factor in acute myeloblastic leukemia cells. Leukemia 9:425.
38. Faggioli, L., C. Costanzo, M. Merola, E. Bianchini, A. Furia, A. Carsana, and M. Palmieri. 1996. Nuclear factor kappa B (NF-kappa B). nuclear factor interleukin-6 (NFIL-6 or C/EBP beta) and nuclear factor interleukin-6 beta (NFIL6-beta or C/EBP delta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7: comparative analysis with MDA-MB-231 cells, an interleukin-6-expressing human breast carcinoma cell line. Eur. J. Biochem. 239:624.
39. Lee, F. S., J. Hagler, Z. J. Chen, and T. Maniatis. 1997. Activation of the IκB-α kinase complex by MEKKI, a kinase of the JNK pathway. Cell 88:213.
40. Yang-Yen, H.-F., J.-C. Chambard, Y.-L. Sun, T. Smeal, T. J. Schmidt, J. Drouin, and M. Karin. 1990. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205.
41. Udagwa, T., D. G. Woodside, and B. W. McIntyre. 1996. Alpha 4 beta 1 (CD49d/ CD29) integrin costimulation of human T cells enhances transcription factor and cytokine induction in the absence of altered sensitivity to anti-CD3 stimulation. J. Immunol. 157:1965.
42. Thompson, J. E., R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IκB-β regulates the persistent response in a biphasic activation of NF-βκB. Cell 80:573.
43. Haskill, S., A. A. Beg, S. M. Tompkins, J. S. Morris, A. D. Yurochko, A. Sampson-Johannes, K. Mondal, P. Ralph, and A. S. Baldwin. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell 65:1281.
44. Yin, T. G., P. Schendel, and Y. C. Yang. 1992. Enhancement of in vitro and in vivo antigen-specific antibody responses by interleukin 11. J. Exp. Med. 175:211.
45. Anderson, K. C., C. Morimoto, S. R. Paul, D. Chauhan, D. Williams, M. Cochran, and B. A. Barut. 1992. Interleukin-11 promotes accessory cell-dependent B-cell differentiation in humans. Blood 80:2797.
46. Donnelly, R. P., S. Freeman, and M. P. Hayes. 1995. Inhibition of IL-10 expression by IFN-γ up-regulates transcription of TNF-α in human monocytes. J. Immunol. 155:1420.
47. Kunsch, C., S. M. Ruben, and C. A. Rosen. 1992. Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation. Mol. Cell. Biol. 12:4412.
48. Shirakawa, F., K. Saito, C. A. Bonagura, D. L. Galson, M. J. Fenton, A. C. Webb, and P. E. Auron. 1993. The human prointerleukin 1 beta gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction. Mol. Cell. Biol. 13:1332.
49. Drouet, C., A. N. Shakhov, and C. V. Jongeneel. 1991. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-alpha promoter in primary macrophages. J. Immunol. 147:1694.
50. Libermann, T. A., and D. Baltimore. 1990. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell. Biol. 10:2327.
51. Matsusaka, T., K. Fujikawa, Y. Nishio, N. Mukaida, K. Matsushima, T. Kishimoto, and S. Akira. 1993. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl. Acad. Sci. USA 90:10193.
52. Yasumoto, K., S. Okamoto, N. Mukaida, S. Murakami, M. Mai, and K. Matsushima. 1992. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene. J. Biol. Chem. 267:22506.
53. Kerppola, T. K., D. Luk, and T. Curran. 1993. Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro. Mol. Cell. Biol. 13: 3782.
54. Konig, H., H. Ponta, H. J. Rahmsdorf, and P. Herrlich. 1992. Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J. 11:2241.
55. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723.
56. Beg, A. A., and A. Baldwin, Jr. 1993. The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev. 7:2064.
57. Fukuda, Y., and S. Sassa. 1993. Effect of interleukin-11 on the levels of mRNAs encoding heme oxygenase and haptoglobin in human HepG2 hepatoma cells. Biochem. Biophys. Res. Commun. 193:297.
58. Weih, F., D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rizzo, R. P. Ryseck, S. A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with targeted disruption of RelB, a member of the NF-κB/ Rel family. Cell 80:331.
59. Neurath, M. F., S. Pettersson, K. H. Meyer zum Buschenfelde, and W. Strober. 1996. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat. Med. 2:998.
60. Leng, S.X., and J. A. Elias. 1997. Interleukin-11 inhibits macrophage interleukin-12 production. J. Immunol. 159:2161.